Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03945422
Other study ID # DO608522A
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 15, 2019
Est. completion date January 18, 2021

Study information

Verified date January 2022
Source InMode MD Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study is to evaluate the efficacy of treatment Radio Frequency in premature jowl and neck laxity following facialplasty


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date January 18, 2021
Est. primary completion date January 18, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - Adult females and males between the ages of 40-80 inclusive, having premature jowl and/or neck laxity one to fifteen years following facialplasty, seeking skin tightening treatments. - Lack lipodystrophy in the jowl or neck area or at least not amenable to liposuction improvement (not a candidate for liposuction). - Lack of previous Face Lift complications (no nerve injury or hematoma history). - The patients should understand the information provided about the investigative nature of the treatment, possible benefits and side effects, and sign the Informed Consent Form, (including thepermission to use photography). - The patients should be willing to comply with the study procedure and schedule, including the follow up visit, and will refrain from using any other aesthetic treatment methods for the last 6 months and during the entire study period. Exclusion Criteria: - Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body. - The Handpiece should be used at least 1cm away from cochlear implants in the ear. - Superficial permanent implant in the treated area such as metal plates and screws, metal piercing, silicone implants or an injected chemical substance. - Current or history of skin cancer (remission of 5 years), or current condition of any other type of cancer, or pre-malignant moles. - Severe concurrent conditions, such as cardiac disorders, epilepsy, uncontrolled hypertension, and liver or kidney diseases. - Pregnancy and nursing. - History of bleeding coagulopathies or use of anticoagulants - Impaired immune system due to immunosuppressive diseases such as AIDS and HIV or use of immunosuppressive medications. - Poorly controlled endocrine disorders, such as diabetes or thyroid dysfunction and hormonalvirilization. - Any active condition in the treatment area, such as sores, psoriasis, eczema, and rash. - History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile skin. - Use of Isotretinoin (Accutane®) within 6 months prior to treatment. - Any surgery or treatment such as laser or chemicals in treated area within 3-6 months prior to treatment or before complete healing. - Allergies, in particular to anesthesia. - Mental disorders such as Body Dysmorphic Disorder (BDD). - As per the practitioner's discretion, refrain from treating any condition that might make it unsafe for the patient.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
AccuTite/FaceTite
Radiofrequency-assisted lipolysis (RFAL) Morpheus8: Fractional RF

Locations

Country Name City State
United States Chicago Center for Facial Plastics Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
InMode MD Ltd.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in skin appearance Photos from all time points (baseline and follow-up visits) will be evaluated by the treating physician and 2 independent evaluators. 3 months, 6 month, 9 months
Secondary Investigator assessment of the skin appearance Investigator assessment of the skin appearance improvement comparing pre and post treatment using 0 - 4 -points Likert scale: 4 = Significantly marked improvement; 3 = Marked improvement; 2 = Moderate improvement; 1 = Slight improvement ; 0 = No difference. 3 Month, 6 Months, 9 Months
Secondary Optional: 3D Photographic analysis 3D Photographic analysis will be conducted using QuantifiCare System 3 months, 6 month, 9 months
Secondary Evaluate changes in skin appearance comparing photographs using Mechanical Turk (MTurk). The pictures will be sent through the system and evaluated by crowd workers. The pictures will be sent through the system and evaluated by crowd workers. 3 Months, 6 Months